BICD2 Gene Spinal Muscular Atrophy Lower Extremity Autosomal Dominant Type 2 Genetic Test sale cost 4400 AED
TFG Gene SPG57 Genetic Test sale cost 4400 AED TFG Gene SPG57 Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
WWOX Gene Spinocerebellar Ataxia Type 12 Autosomal Recessive Genetic Test sale cost 4400 AED WWOX Gene Spinocerebellar Ataxia Type 12 Autosomal Recessive Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

BICD2 Gene Spinal Muscular Atrophy Lower Extremity Autosomal Dominant Type 2 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The BICD2 Gene Spinal Muscular Atrophy Lower Extremity Autosomal Dominant Type 2 (SMA-LED2) genetic test is a specialized diagnostic tool used to detect mutations in the BICD2 gene, which are known to cause SMA-LED2. This condition is characterized by muscle weakness and atrophy predominantly affecting the lower limbs, often leading to difficulties in walking and mobility. It is inherited in an autosomal dominant pattern, meaning that only one copy of the altered gene is sufficient to cause the disorder.

The test is conducted at DNA Labs UAE, a reputable facility known for its comprehensive genetic testing services. The process involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the lab to identify any mutations in the BICD2 gene.

The cost of the BICD2 Gene Spinal Muscular Atrophy Lower Extremity Autosomal Dominant Type 2 genetic test is 4400 AED. While the price may seem steep, it’s important to consider the value of the information it provides, which can be crucial for early diagnosis, management, and treatment planning for affected individuals and their families. Early detection through this genetic test can significantly improve the quality of life for those with SMA-LED2 by allowing for timely interventions and support.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

BICD2 Gene Spinal Muscular Atrophy Lower Extremity Autosomal Dominant Type 2 Genetic Test

Test Name: BICD2 Gene Spinal muscular atrophy lower extremity autosomal dominant type 2 Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test type: Neurological Disorders

Doctor: Neurologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for BICD2 Gene Spinal muscular atrophy, lower extremity, autosomal dominant, type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with BICD2 Gene Spinal muscular atrophy, lower extremity, autosomal dominant, type 2.

Test Details: The BICD2 gene is associated with a genetic condition called spinal muscular atrophy, lower extremity, autosomal dominant, type 2 (SMALED2). This condition is characterized by muscle weakness and atrophy, particularly in the lower extremities. It is inherited in an autosomal dominant manner, meaning that a person only needs to inherit one copy of the mutated gene from either parent to develop the condition. NGS (Next-Generation Sequencing) genetic testing refers to a type of genetic testing that utilizes advanced sequencing technologies to analyze multiple genes simultaneously. In the context of SMALED2, NGS genetic testing can be used to identify mutations or variations in the BICD2 gene that may be responsible for the condition. This testing can help confirm a diagnosis, provide information about the specific genetic variant causing the condition, and assist in genetic counseling and family planning. It is important to note that genetic testing should be conducted and interpreted by a qualified healthcare professional or genetic counselor who can provide accurate and comprehensive information about the results and their implications.

Test Name BICD2 Gene Spinal muscular atrophy lower extremity autosomal dominant type 2 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for BICD2 Gene Spinal muscular atrophy, lower extremity, autosomal dominant, type 2 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with BICD2 Gene Spinal muscular atrophy, lower extremity, autosomal dominant, type 2
Test Details

The BICD2 gene is associated with a genetic condition called spinal muscular atrophy, lower extremity, autosomal dominant, type 2 (SMALED2). This condition is characterized by muscle weakness and atrophy, particularly in the lower extremities. It is inherited in an autosomal dominant manner, meaning that a person only needs to inherit one copy of the mutated gene from either parent to develop the condition.

NGS (Next-Generation Sequencing) genetic testing refers to a type of genetic testing that utilizes advanced sequencing technologies to analyze multiple genes simultaneously. In the context of SMALED2, NGS genetic testing can be used to identify mutations or variations in the BICD2 gene that may be responsible for the condition. This testing can help confirm a diagnosis, provide information about the specific genetic variant causing the condition, and assist in genetic counseling and family planning.

It is important to note that genetic testing should be conducted and interpreted by a qualified healthcare professional or genetic counselor who can provide accurate and comprehensive information about the results and their implications.

SKU: TEST-2047